Prescribing Trends and Associated Outcomes of Antiepileptic Drugs in US Nursing Homes Surrounding the COVID-19 Pandemic
Part of paid clinical trials in Richmond, Virginia.
- Sponsor
- Virginia Commonwealth University
- Study ID
- NCT06095284
- Status
- Enrolling By Invitation
Conditions
- Dementia
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Pre-Extraction Phase — OTHERThis intervention requires the following procedures: Submitting data use agreement, MDS request defined and developed, Part D request, CMS public use file request defines and develop questionnaire
- Extraction Phase — OTHERProcedures include: Access VRDC for 2 years, Crosswalk CMS files and MDS using ID's, Preliminary analysis for validity/accuracy, Request revision/resubmission, Linked dataset created in VRDC and Distribute Questionnaire
- Post-Extraction Phase — OTHERProcedures include: De-identified data securely stored, analysis, dissemination and knowledge translation
Study Details
Since the "National Partnership to Improve Dementia Care" debuted in 2012, almost all long-stay psychoactive prescribing has been graded by CMS, which has correlated to decreased use. However, some national data suggest that while these psychoactive medications are being used less, prescriptions of mood-stabilizing antiepileptic drugs (AEDs) have increased. Unlike all other psychoactive medications, AEDs prescribed in nursing homes are not mandatorily reported to CMS or graded in a quality-measure.
Key Dates
- Start date
- Sep 1, 2022
- Status verified
- Oct 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 22,500,000 participants (estimated)
Arms
- Arm: All nursing home residents included in the 2009-2021 MDSAll nursing home residents included in the 2009-2021 MDS
- Arm: Nursing home and non-nursing home residents diagnosed with an AD/ADRD conditionNursing home and non-nursing home residents diagnosed with an AD/ADRD condition
Primary Outcome Measure
Quarterly rate of use and mean dose of AEDs in US nursing homes [ Time Frame: The years 2009 to 2021 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Virginia Commonwealth University | Richmond | Virginia | 23298 | - |
Find similar trials in Richmond, VA
By research site
Related Studies
- Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older AdultsPHASE4 · Recruiting · Duke University · Birmingham, Alabama
- Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's DiseasePHASE2 · Recruiting · Eastern Virginia Medical School · Norfolk, Virginia
- Persons With Dementia and Their Extended Family CaregiversRecruiting · Karen Roberto · Blacksburg, Virginia
- Exploration of an Online Education Program to Support Caregivers' Knowledge TransferPHASE1 · Recruiting · Texas Christian University · Fort Worth, Texas